We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Oncology

Journal Scan / Research · January 23, 2020

Brentuximab Vedotin With Chemotherapy for Stage III/IV Classical Hodgkin Lymphoma

Blood

 

Additional Info

Blood
Brentuximab Vedotin With Chemotherapy for Stage III/IV Classical Hodgkin Lymphoma: 3-Year Update of the ECHELON-1 Study
Blood 2020 Jan 16;[EPub Ahead of Print], DJ Straus, M Długosz-Danecka, S Alekseev, A Illes, M Picardi, E Lech-Maranda, T Feldman, P Smolewski, KJ Savage, NL Bartlett, J Walewski, R Ramchandren, PL Zinzani, M Hutchings, JM Connors, J Radford, J Munoz, WS Kim, R Advani, SM Ansell, A Younes, H Miao, R Liu, K Fenton, A Forero, A Gallamini

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading